Stockreport

KalVista Pharmaceuticals Touts EKTERLY Launch: Nearly $50M in Under 6 Months, 20% Patient Reach [Yahoo! Finance]

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com
PDF has reached something over 20% of patients, with about 1,700 start forms and ~724 prescribing physicians amid early U.S., German and Japanese launches. Coverage is cur [Read more]